Antimicrobial activity of Ankaferd Blood StopperA (R) against nosocomial bacterial pathogens


SARIBAŞ Z., ŞENER B., HAZNEDAROĞLU İ. C., Hascelik G., Kirazli S., GÖKER H.

CENTRAL EUROPEAN JOURNAL OF MEDICINE, vol.5, no.2, pp.198-202, 2010 (SCI-Expanded) identifier identifier

Abstract

The aim of this study is to investigate the in vitro antimicrobial activity of Ankaferd Blood StopperA (R) against methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus species, Escherichia coli, Pseudomonas species, Acinetobacter species and Klebsiella species of nosocomial origin. Ankaferd inhibited growth in 72.4% to 100% of the bacteria tested, depending on the type of the isolate. As a result, it can be stated that Ankaferd inhibits the in vitro growth of nosocomial bacteria. This is a novel, important finding since severe hospital infections coexist with many hemostatic disorders, and the use of Ankaferd may increase hemostatic potential in such clinical conditions.